Aurobindo Pharma Limited — Updates, 24-07-2026: Press Release
24-07-2026 | 09:47 pm
24-07-2026 | 09:47 pm
Aurobindo Pharma signed a royalty-free license with MSD to produce and supply generic alimatravir for HIV prevention in 129 low- & middle-income countries. This partnership boosts Aurobindo's global reach and commitment to expanding access to vital medicines.
No comments yet. Be the first to comment!
